CiDD specifications

Information


Unique identifier OMICS_25796
Name CiDD
Alternative name Cancer in silico Drug Discovery
Software type Application/Script
Interface Command line interface
Restrictions to use Academic or non-commercial use
Input data A clinical or molecular characteristic.
Output data A biologically annotated list of candidate drugs to target that characteristic and a list of cell lines for in vitro experimentation.
Operating system Unix/Linux, Mac OS
Programming languages Python, R
License GNU General Public License version 3.0
Computer skills Advanced
Stability Stable
Requirements numpy, scipy, Ixml
Registration required Yes
Maintained Yes

Versioning


Add your version

Maintainers


  • person_outline Eduardo Vilar <>
  • person_outline Paul Scheet <>

Publication for Cancer in silico Drug Discovery

CiDD institution(s)
The Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA; Department of Epidemiology, The University of Texas - M.D. Anderson Cancer Center, Houston, TX, USA; Department of Gastrointestinal Medical Oncology, The University of Texas– M.D. Anderson Cancer Center, Houston, TX, USA; Clinical Cancer Prevention, The University of Texas – M.D. Anderson Cancer Center, Houston, TX, USA
CiDD funding source(s)
Supported by the Schissler Foundation, the Conquer Cancer Foundation of the American Society of Clinical Oncology and Young Investigator Award and by the National Institutes of Health grants 1R03CA176788-01A1 and U24 CA143883 and U01 GM 92666 and R01HG005859 and 1R01CA172670-01 and by The University of Texas MD Anderson Cancer Center Core Support Grant.

CiDD reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review CiDD